MedHab, LLC
USPTO PatentsView assignee record - 10 granted patents across 12 technology areas, recorded in grant years 2016–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Medhab ranks #26,826 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 12 technology areas.
- #26,826
- of 49,997 US assignees by volume
- 16th percentile
- by Innovation Score (25.1/100)
- 7.6
- avg claims per patent
- -89%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R26826 · US Corporation #26,826 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 10 grants
- MID-PACK #26,826/49,997
- PHOTO-FINISH Max-Delbrück-Centrum…
- CPC-FOCUS A61B · 12 areas
- INNOV-THIN 25.1/100
- CLAIMS-SPARSE 7.6 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -89% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Max-Delbrück-Centrum Für Molekulare Medizin (MDC) Berlin-Buch (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Medhab’s 25.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Medhab
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- MedHab · this assignee 25
MedHab · this assignee
25 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Medhab's Innovation Score is 25.1/100 (16th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Medhab?
Each dot is one of Medhab’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medhab’s own 7.6 claims/patent is at or below the 11.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Medhab's grants concentrate
MedHab, LLC is a focused PatentsView assignee: 12 CPC subclasses with 60% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2017. By volume, Medhab sits between Max-Delbrück-Centrum Für Molekulare Medizin (MDC) Berlin-Buch and Medicenna Therapeutics Inc..
Who files at MedHab's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Max-delbrück-cent…
Max-Delbrück-Centrum Für Molekulare Medizin (MDC) Berlin-Buch
10 patents
- Maxar Intelligence
Maxar Intelligence Inc.
10 patents
- Maxout Renewable
Maxout Renewable, Inc.
10 patents
- Measurement Speci…
Measurement Specialties (Chengdu) Ltd
10 patents
- Medisynergics
MediSynergics, LLC
10 patents
- Medivena Sp z o o
MediVena Sp. z o.o.
10 patents
- Medicasafe
Medicasafe, Inc.
10 patents
- Medicenna Therape…
Medicenna Therapeutics Inc.
10 patents
- Medhab ◀
MedHab, LLC
10 patents
What this shows MedHab holds 10 patents at rank #26,869, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near MedHab
By rank, the assignees closest to #26,869 in granted patent volume.
- Max-Delbrück-Centrum Für Molekulare Medizin (MDC) Berlin-Buch #26,865 · 10 patents
- Maxar Intelligence Inc. #26,866 · 10 patents
- Maxout Renewable, Inc. #26,867 · 10 patents
- Measurement Specialties (Chengdu) Ltd #26,868 · 10 patents
- MediSynergics, LLC #26,870 · 10 patents
- MediVena Sp. z o.o. #26,871 · 10 patents
- Medicasafe, Inc. #26,872 · 10 patents
- Medicenna Therapeutics Inc. #26,873 · 10 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in MedHab's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Medhab's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
25 16th percentile higher than 16% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 20.0% |
| 2017 | 1 | 10.0% |
| 2018 | 2 | 20.0% |
| 2019 | 4 | 40.0% |
| 2020 | 1 | 10.0% |
Which technologies does MedHab, LLC patent most?
Top 12 of 12 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
MedHab, LLC's patent record in context - here's where to go next.
- MedHab, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 60% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #26,826 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare MedHab, LLC against Max-Delbrück-Centrum Für Molekulare Medizin (MDC) Berlin-Buch, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 25.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.